ASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica Journal

Ads

You May Also Like

Coherus BioSciences Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Sept. 16, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

CoLucid Pharmaceuticals Announces Special Protocol Agreement for SPARTAN

CAMBRIDGE, Mass., March 01, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a Phase 3 ...